We talk with Dr. Florian Krammer, the endowed Mount Sinai Professor of Vaccinology at the Icahn School of Medicine, New York, NY and Director of the Ludwig Boltzmann Institute for Science Communication and Pandemic Preparedness at the Medical University of Vienna, Austria, who studies the B cell response in the context of natural infection to better understand how to design broadly protective and durable vaccines.

We talk with Dr. John Gridley, a postdoctoral fellow in the Vaccinology Training Program at Emory University, GA, who uses a hepatitis C virus-related rodent hepacivirus model to identify correlates of protective immunity for HCV and the role of inducible Hepatic-Associated Lymphoid Tissue (iHALT) in the induction of this immune response.

We talk with Dr. Sandro Galea, Dean and Professor of the School of Public Health at Washington University in St. Louis, who uses population based sciences to promote health locally and globally.

We talk with Dr. Hedda Wardemann, Division Head of B Cell Immunology at the German Cancer Research Center and Professor at the Medical Faculty of the University of Heidelberg in Heidelberg, Germany, who studies B cell responses in the context of infectious disease and cancer.

. 

We talk with Dr. Emanuele Andreano, Head of Serology and Immunology at Fondazione Biotecnopolo di Siena, Italy, who combines immunology, structural biology and artificial intelligence to rapidly develop novel monoclonal antibodies therapies and antiviral vaccine targets.

We talk with Dr. Daniel Wrapp, Assistant Professor Assistant Professor at the Duke Human Vaccine Institute at Duke University School of Medicine, NC, who uses structure-based design to develop novel therapeutic interventions against viruses.

We talk with Dr. Paeton Wantuch, a Staff Scientist in the Department of Pediatrics at Washington University School of Medicine, MO, who uses animal models to understand correlates of protection for vaccines against Klebsiella pneumoniae.

We talk with Dr. Cassie Simonich, Pediatric Infectious Diseases Fellow at the University of Washington, WA, who uses RSV pseudoviruses and deep mutational scanning approaches to define the evolution of the RSV fusion protein to escape natural or vaccine-induced immunity and monoclonal antibody treatments.

We talk with Dr. Alba Grifoni, Research Assistant Professor scholar in the Center for Vaccine Innovation at the La Jolla Institute for Immunology, CA, who uses bioinformatic analyses and immune focusing approaches to improve protective T cell responses induced by vaccines.

We talk with Dr. Alexander Cohen, Postdoctoral Scholar in the Division of Biology and Biological Engineering at the California Institute of Technology, CA, who uses immune focusing approaches to design vaccines that generate antibodies against conserved epitopes on viral antigens.